CV Therapeutics ( CVTX) said late Thursday that it had a narrower fourth-quarter loss than expected, while revenue jumped past targets. The stock was recently adding 76 cents, or 6.1%, to $13.15.

Monogram Biosciences ( MGRM) was higher after reporting a fourth-quarter loss that narrowed from a year ago and was in line with expectations. Monogram was adding 7 cents, or 4%, to $1.83.

Cell Therapeutics ( CTIC) was trading lower a day after the company announced it will sell $17.6 million of convertible preferred stock and warrants. Cell Therapeutics was losing 6 cents, or 3.7%, to $1.57.

Among health care stocks gaining ground, Cell Genesys ( CEGE) was surging 7.9% to $3.57. MedImmune ( MEDI) was adding 1.5% to $31.87. GlaxoSmithKline ( GSK) was tacking on 1.4% to $56.62.

Among decliners, Amylin Pharmaceuticals ( AMLN) fell 2.1% to $40.79. Gilead Sciences ( GILD) was off 1.6% to $70.98. Forest Laboratories ( FRX) was slipping 1.5% to $54.53.

More from Investing

Dunkin' Donuts Drops 'Donuts' from Its Name (But Not Its Shelves)

Dunkin' Donuts Drops 'Donuts' from Its Name (But Not Its Shelves)

Harvard Report Calls for Regulation of Facebook, Big Tech

Harvard Report Calls for Regulation of Facebook, Big Tech

Bonds at Important Level as Market Awaits Fed Decision

Bonds at Important Level as Market Awaits Fed Decision

Is This the End of Instagram As We Know It?

Is This the End of Instagram As We Know It?

Jim Cramer: Disruption Is What Mattered Today

Jim Cramer: Disruption Is What Mattered Today